Arerugi = [Allergy]最新文献

筛选
英文 中文
[CLINICAL FEATURE AND EXAMINATION OF CONTACT DERMATITIS]. 【接触性皮炎的临床特点及检查】。
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.156
Atsuko Adachi
{"title":"[CLINICAL FEATURE AND EXAMINATION OF CONTACT DERMATITIS].","authors":"Atsuko Adachi","doi":"10.15036/arerugi.70.156","DOIUrl":"https://doi.org/10.15036/arerugi.70.156","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 3","pages":"156-164"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39000133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.1403
{"title":"","authors":"","doi":"10.15036/arerugi.70.1403","DOIUrl":"https://doi.org/10.15036/arerugi.70.1403","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":" ","pages":"1403-1404"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39841124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[THE STATUS OF ADMISSION TO FACILITIES FOR CHILDREN WITH FOOD ALLERGIES]. [食物过敏儿童的入院情况]。
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.293
Noriko Hayashi, Noriyuki Yanagida, Kiyotake Ogura, Kyohei Takahashi, Summi Park, Yasuko Watanabe, Kemal Sasaki, Sakura Sato, Motohiro Ebisawa
{"title":"[THE STATUS OF ADMISSION TO FACILITIES FOR CHILDREN WITH FOOD ALLERGIES].","authors":"Noriko Hayashi,&nbsp;Noriyuki Yanagida,&nbsp;Kiyotake Ogura,&nbsp;Kyohei Takahashi,&nbsp;Summi Park,&nbsp;Yasuko Watanabe,&nbsp;Kemal Sasaki,&nbsp;Sakura Sato,&nbsp;Motohiro Ebisawa","doi":"10.15036/arerugi.70.293","DOIUrl":"https://doi.org/10.15036/arerugi.70.293","url":null,"abstract":"<p><strong>Background: </strong>To clarify the status of admission to facilities for food allergy (FA) children.</p><p><strong>Methods: </strong>Guardians of FA children who underwent oral food challenges at Sagamihara National Hospital from September to December 2018 were enrolled. We surveyed the experience of refusal to enter facilities, the reason for refusal and so on using a self-administered questionnaire.</p><p><strong>Results: </strong>We distributed a questionnaire to 205 guardians, of which 168 responded (response rate 82%). The median age (range) at the time of the survey was 4.5 (0 to 12) years old, 2 (1 to 11) food items had been removed at the time of admission, and 56 (33%) had a history of anaphylaxis before admission. Twenty-nine patients (17%) were prescribed an adrenaline auto injector. Twenty patients (12%) had been denied entry, the median number of refusals (range) was 1.5 (1 to 30). History of anaphylaxis before admission (odds ratio 2.80 [1.08-7.22]) and having 5 or more causative foods (odds ratio 3.44 [1.27-9.32]) were associated with admission refusal. 〔' Factors related to children with FA〕, 〔Factors related to facilities〕, and 〔Factors related to facility staff〕 were extracted as the reasons for refusal.</p><p><strong>Conclusions: </strong>In addition to the factors related to children with FA, the factors related to facilities and facility staff were related to admission refusal. Therefore, cooperation between medical care, local governments, and facility that comprehensively supports the living environment of children with FA is needed.</p>","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 4","pages":"293-301"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39239348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A PEDIATRIC CASE OF DIFFUSE PANBRONCHIOLITIS WHO PREDOMINANTLY SHOWED RESTRICTIVE PULMONARY DYSFUNCTION AND DRAMATICALLY RESPONDED TO MACROLIDE LOW-DOSE LONG-TERM THERAPY.] [1例弥漫性泛细支气管炎患儿,主要表现为限制性肺功能障碍,对大环内酯低剂量长期治疗有显著反应。]
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.310
Katsuhiko Tabata, Yutaka Ueda, Keisuke Okada, Takahiro Shimizu, Shunichi Ogawa, Takeshi Koga, Eiji Morita, Toshiko Itazawa, Kenichi Tokuyama
{"title":"[A PEDIATRIC CASE OF DIFFUSE PANBRONCHIOLITIS WHO PREDOMINANTLY SHOWED RESTRICTIVE PULMONARY DYSFUNCTION AND DRAMATICALLY RESPONDED TO MACROLIDE LOW-DOSE LONG-TERM THERAPY.]","authors":"Katsuhiko Tabata,&nbsp;Yutaka Ueda,&nbsp;Keisuke Okada,&nbsp;Takahiro Shimizu,&nbsp;Shunichi Ogawa,&nbsp;Takeshi Koga,&nbsp;Eiji Morita,&nbsp;Toshiko Itazawa,&nbsp;Kenichi Tokuyama","doi":"10.15036/arerugi.70.310","DOIUrl":"https://doi.org/10.15036/arerugi.70.310","url":null,"abstract":"<p><p>A 12-year-old boy visited our hospital with complaints of chronic cough and dyspnea. Chest X-ray and CT revealed diffuse granular shadow in the bilateral lung fields and \"Tree-in-bud appearance\" in the peripheral airways, respectively. Sinusitis was present, and restrictive disorder was predominantly found in pulmonary function. The patient was diagnosed with DPB, and long-term therapy was started with low-dose clarithromycin (CAM), The patient showed a dramatic response to CAM, with improvements of both the clinical symptoms and pulmonary function within 1-2 months. According to the relevant literature, in adult patients with this disease, pulmonary dysfunction starts from an obstructive pattern; however, this is not the case in pediatric patients. It was therefore suggested that the mechanisms underlying the development of pulmonary dysfunction in cases of childhood onset differs from those with an adult onset.</p>","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 4","pages":"310-314"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39239352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.396
{"title":"","authors":"","doi":"10.15036/arerugi.70.396","DOIUrl":"https://doi.org/10.15036/arerugi.70.396","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 5","pages":"396-397"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39195816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Erratum : MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE Vol.70 (2021) No.3 p.215-223]]. [勘误:严重过敏反应的管理、诊断和治疗,包括COVID-19疫苗过敏反应,Vol.70 (2021) No.3 p.215-223]。
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.489
Koichiro Asano, Takao Fujisawa, Yoichi Nakamura, Makoto Nagata, Michihiro Hide, Shigeharu Fujieda
{"title":"[Erratum : MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE Vol.70 (2021) No.3 p.215-223]].","authors":"Koichiro Asano,&nbsp;Takao Fujisawa,&nbsp;Yoichi Nakamura,&nbsp;Makoto Nagata,&nbsp;Michihiro Hide,&nbsp;Shigeharu Fujieda","doi":"10.15036/arerugi.70.489","DOIUrl":"https://doi.org/10.15036/arerugi.70.489","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 5","pages":"489"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39195818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.594
{"title":"","authors":"","doi":"10.15036/arerugi.70.594","DOIUrl":"https://doi.org/10.15036/arerugi.70.594","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 6-7","pages":"594-643"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39469463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[NOVEL THERAPEUTICS FOR ATOPIC DERMATITIS∼BIOLOGICS∼]. [特应性皮炎的新疗法~生物制剂~]。
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.913
Ken Igawa
{"title":"[NOVEL THERAPEUTICS FOR ATOPIC DERMATITIS∼BIOLOGICS∼].","authors":"Ken Igawa","doi":"10.15036/arerugi.70.913","DOIUrl":"https://doi.org/10.15036/arerugi.70.913","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 8","pages":"913-917"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39469901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[IMMUNOTHERAPY:SUBLINGUAL IMMUNOTHERAPY AND ANTI-IGE THERAPY FOR JAPANESE CEDAR POLLINOSIS IN JAPAN]. [免疫治疗:舌下免疫治疗和抗ige治疗在日本杉木授粉病]。
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.948
Kimihiro Okubo
{"title":"[IMMUNOTHERAPY:SUBLINGUAL IMMUNOTHERAPY AND ANTI-IGE THERAPY FOR JAPANESE CEDAR POLLINOSIS IN JAPAN].","authors":"Kimihiro Okubo","doi":"10.15036/arerugi.70.948","DOIUrl":"https://doi.org/10.15036/arerugi.70.948","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 8","pages":"948-954"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39469907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[ALLERGIC DISEASES IN ADULT-ONSET STILL'S DISEASE AND RHEUMATOID ARTHRITIS]. [成人发病的过敏性疾病still 's病和类风湿关节炎]。
Arerugi = [Allergy] Pub Date : 2021-01-01 DOI: 10.15036/arerugi.70.965
Misako Higashida-Konishi, Keisuke Izumi, Tatsuya Shimada, Satoshi Hama, Mitsuhiro Akiyama, Hisaji Oshima, Yutaka Okano
{"title":"[ALLERGIC DISEASES IN ADULT-ONSET STILL'S DISEASE AND RHEUMATOID ARTHRITIS].","authors":"Misako Higashida-Konishi,&nbsp;Keisuke Izumi,&nbsp;Tatsuya Shimada,&nbsp;Satoshi Hama,&nbsp;Mitsuhiro Akiyama,&nbsp;Hisaji Oshima,&nbsp;Yutaka Okano","doi":"10.15036/arerugi.70.965","DOIUrl":"https://doi.org/10.15036/arerugi.70.965","url":null,"abstract":"<p><strong>Background: </strong>A high prevalence of allergic diseases was found in patients with adult-onset Still's disease (AOSD). However, the relative prevalence is unknown compared with other diseases.</p><p><strong>Objectives: </strong>We sought to compare the prevalence of allergic diseases in the control group of patients with rheumatoid arthritis (RA).</p><p><strong>Methods: </strong>We retrospectively examined consecutive patients diagnosed with AOSD or RA in our hospital from 2010 to 2020. The patients with AOSD met the preliminary criteria for classification of AOSD. The patients with RA met the EULAR/ACR 2010 criteria. We included patients with RA without other rheumatic diseases. The analysis was performed on six types of allergic reactions: food allergy, drug allergy, allergic contact dermatitis, allergic rhinitis and/or allergic conjunctivitis, and asthma.</p><p><strong>Results: </strong>Twenty-four patients with AOSD and 409 patients with RA were enrolled. The median ages (AOSD, RA) were 46.6, 68.2 years old. Females were 83.3%, 78.0%. Fifty% of AOSD patients and 34.5% of RA patients presented at least one type of allergic diseases (p = 0.12). These included food allergy (4.2%, 6.4%: p = 1.0), drug allergy (37.5%, 16.6%: p = 0.02), allergic rhinitis/allergic conjunctivitis (25.0%, 8.6%: p = 0.02), contact dermatitis (4.2%, 4.4%: p = 1.0), and asthma (4.2%, 5.9%: p = 1.0).</p><p><strong>Conclusion: </strong>Patients with AOSD had a higher prevalence of drug allergy, and allergic rhinitis/allergic conjunctivitis than patients with RA.</p>","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"70 8","pages":"965-975"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39469908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书